Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|February 16, 1980
Development of a quantitative immunoassay for the cystic fibrosis geneJ C Manson, D J Brock
The EMBO Journal|November 1, 1986
A protein specific to mitochondria from S-type male-sterile cytoplasm of maize is encoded by an episomal DNAJ C Manson, A D Liddell, C J Leaver, et al.
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|December 1, 1994
PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathologyJ C Manson, A R Clarke, P A McBride, et al.
Biochemical Society Transactions|November 1, 2006
The transmissible spongiform encephalopathies: emerging and declining epidemicsJ C Manson, E Cancellotti, P Hart, et al.
Molecular Neurobiology|April 1, 1994
129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normalJ C Manson, A R Clarke, M L Hooper, et al.
European Journal of Immunology|February 1, 1989
Autoregulation of interleukin 1 productionJ C Manson, J A Symons, F S Di Giovine, et al.
Bio/Technology (Nature Publishing Company)|September 1, 1995
Double replacement gene targeting for the production of a series of mouse strains with different prion protein gene alterationsR C Moore, N J Redhead, J Selfridge, et al.
Nature Genetics|February 14, 1998
Mice with gene targetted prion protein alterations show that Prnp, Sinc and Prni are congruentR C Moore, J Hope, P A McBride, et al.
Archives of Virology. Supplementum|February 24, 2001
A single amino acid alteration in murine PrP dramatically alters TSE incubation timeJ C Manson, R Barron, E Jamieson, et al.
Pageof 2